10:57 EDT Corcept Therapeutics (CORT) trading resumes
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CORT:
- FDA approves Corcept Therapeutics’ Lifyorli for certain cancers
- Corcept Therapeutics jump 10% after FDA approves Lifyorli cancer treatment
- Corcept Therapeutics trading halted, volatility trading pause
- Corcept Therapeutics management to meet with Piper Sandler
- Corcept Therapeutics director buys $3.3M in common stock